RATIONALITY OF ANTIBIOTIC PRESCRIPTIONS AMONG OUTPATIENTS IN THE INTERNAL MEDICINE CLINIC AT PERSAHABATAN GENERAL HOSPITAL JULY–SEPTEMBER 2023

Astrid Nada Artanti; Ima Maria; Eldiza Puji Rahmi; Dhigna Luthfiyani Citra Pradana; Diliana Diliana

Astrid Nada Artanti Pharmacy Study Program, Faculty of Medicine, UPN “Veteran” Jakarta, Indonesia
Ima Maria Bachelor of Medicine Program, Faculty of Medicine, UPN “Veteran” Jakarta, Indonesia
Eldiza Puji Rahmi Pharmacy Study Program, Faculty of Medicine, UPN “Veteran” Jakarta, Indonesia
Dhigna Luthfiyani Citra Pradana Pharmacy Study Program, Faculty of Medicine, UPN “Veteran” Jakarta, Indonesia
Diliana Diliana Persahabatan Hospital, Ministry of Health of the Republic of Indonesia

Abstract

Antibiotic use has increased in both developing countries, such as Indonesia, and developed countries, such as Japan and Australia. This trend may lead to a rise in antibiotic resistance if antibiotics are used irrationally. This study aimed to evaluate antibiotic prescribing patterns using the Gyssens method among adult outpatients in the Internal Medicine Clinic at Persahabatan General Hospital during the period of July–September 2023. This was a descriptive study with a cross-sectional design. Data were collected retrospectively from the medical records of adult outpatients attending the Internal Medicine Clinic during the study period. Of the 30 patient records that met the inclusion and exclusion criteria, the age group 51–60 years represented the largest proportion of antibiotic prescriptions (46.67%). Levofloxacin was the most frequently prescribed antibiotic (30.3%). Based on the Gyssens method, 88.8% of prescriptions were classified as rational, while 11.1% were irrational. In conclusion, 88.8% of antibiotics prescribed for adult outpatients in the Internal Medicine Clinic at Persahabatan General Hospital during July–September 2023 were deemed rational according to the Gyssens method.

Keywords : antibiotics, gyssens method, outpatient

DOI : 10.35990/mk.v8n4.p400-411

References

1. Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Nomor 28 Tahun 2021 tentang Pedoman Penggunaan Antibiotik. 2021. Jakarta.
2. Ide S, Ishikane M, Aoyagi K, Ono A, Asai Y, Tsuzuki S, et al. Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013–2018. Plos one, 2023;18(6).
3. Park M, Deo D, Tan SP, Bahtigur N, Lwin N. The effectiveness of an antimicrobial stewardship program in an Australian rural hospital. Aust J Rural Health, 2023;31(3):522-31.
4. Lim AH, Wong ST, Thian SY, Tew WY, Chiew SY, Lee X, et al. Antibiotic prescribing pattern in primary care practice in federal territory Kuala Lumpur and Putrajaya, Malaysia. Int. J. Adv. Life Sci. Res., 2021;1:15-24.
5. Asmawati, Asriati, Jafriati. The Relationship of Rationality of Antibiotic Prescribing with Length of Stay in Adult Patients in the ICU (Intensive Care Unit) of Konawe Hospital. Jurnal Ilmiah Mahasiswa Kesehatan Masyarakat, 2024.
6. Anggraini W, Candra TM, Maimunah S, Sugihantoro H. Evaluasi kualitatif penggunaan antibiotik pada pasien infeksi saluran kemih dengan metode Gyssens. KELUWIH: Jurnal Kesehatan dan Kedokteran, 2020;2(1), 1-8.
7. Diana K, Kumala A, Nurlin N, Tandah MR. Evaluasi penggunaan obat berdasarkan indikator peresepan dan pelayanan pasien di Rumah Sakit Tora Belo. JFIKI, 2021; 7(13):13-9.
8. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The lancet, 2022;399(10325):629-55.
9. Hardiana I, Laksmitawati DR, Ramadaniati HU. Evaluasi penggunaan antibiotika pada pasien pneumonia komunitas di instalasi rawat inap RSPAD Gatot Subroto. Majalah Farmasi dan Farmakologi, 2021;25(1):1-6.
10. Dhillon J. Evaluasi Penggunaan Antibiotik dengan Metode Gyssens dan Hubungannya dengan Luaran Pasien Pneumonia Komunitas yang dirawat Inap di Rumah Sakit Umum Pusat Persahabatan [Tesis]. Jakarta: Universitas Indonesia; 2024.
11. Gyssens IC. Audits for monitoring the quality of antimicrobial prescriptions. Dalam Antibiotic Policies: Theory and Practice 2005 (pp. 197-226). Boston, MA: Springer US.
12. Putra DE, Pramudo SG, Arkhaesi N, Retnoningrum D. Pola pemberian antibiotik di era pandemi COVID-19 (studi kasus di Rumah Sakit Nasional Diponegoro). Med Hosp: J Clin Med, 2021;8(2):194-9.
13. Schoevaerdts D, Sibille FX, Gavazzi G. Infections in the older population: what do we know?. Aging clinical and experimental research, 2021;33(3):689-701.
14. Ibrahim AM, Widyati W, Prasetyadi FO. Analisis kualitatif penggunaan antibiotik pada pasien rujukan dengan metode analisis alur Gyssen di RSPAL Dr. Ramelan Surabaya. MPI, 2020;3(2):88-95.
15. Walker NF, Meintjes G, Wilkinson RJ. HIV-1 and the immune response to TB. Future virology, 2013;8(1):57-80.
16. Bell LC, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nature Rev Microbiol, 2018;16(2):80-90.
17. Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/90/2019 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana HIV. Jakarta, 2019.
18. Hanifah S, Melyani I, Madalena L. Evaluasi Penggunaan Antibiotik dengan Metode ATC/DDD dan DU 90% pada Pasien Rawat Inap KSM Penyakit Dalam di salah satu Rumah Sakit Swasta di Kota Bandung. Farmaka, 2022;20(1):21-6.
19. Wikantiananda T, Tjahjadi AI, Sudjud RW. Antibiotic utilization pattern in the Intensive Care Unit of tertiary hospital in West Java, Indonesia. Int J Integr Health Sci, 2019;7(2):81-7.
20. Infectious Disease Society of America. Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Atlanta, 2017.
21. Le Dault E, Sicard S, Desplans J, Mayet A, Simon F, Aigle L, et al. A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa. Infectious Diseases Now, 2023;53(2):104643.
22. Harrison P, Hogan BJ, Floros L, Davies E. Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance. BMJ, 2016;354.
23. Bulitta JB, Kinzig M, Naber CK, Wagenlehner FM, Sauber C, Landersdorfer CB, et al. Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination. Chemotherapy, 2012;57(5):402-416.
24. Gulyás D, Kamotsay K, Szabó D, Kocsis B. Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone. Microorganisms, 2023;11(6):1602.
25. Shi Y, Dong Y, Huang W, Zhu D, Mao H, Su P. Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis. PLoS One, 2016;11(6):e0157259.
26. Torres A, Liapikou A. Levofloxacin for the treatment of respiratory tract infections. Expert Opin on Pharmacother, 2012;13(8): 1203-1212.
27. Bientinesi R, Murri R, Sacco E. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis. Expert Opin on Pharmacother, 2020;21(6):637-644.
28. Ohkusa T, Koido S. Intestinal microbiota and ulcerative colitis. J Infect Chemother, 2015;21(11):761-8.
29. Sasaki M, Klapproth JM. The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduc, 2012;(1):704953.
30. Arora Z, Mukewar S, Wu X, Shen B. Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis. Gastroenterology Report, 2016;4(4):287-92.
31.Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, et al. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in public health, 2022;10:1025633.